112 related articles for article (PubMed ID: 8446048)
1. Effect of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on triglyceride kinetics in chronically streptozotocin-diabetic rats.
Maeda E; Yoshino G; Matsushita M; Nagata K; Morita M; Murata Y; Naka Y; Kazumi T
Metabolism; 1993 Jan; 42(1):52-7. PubMed ID: 8446048
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat.
Kasim SE; LeBoeuf RC; Khilnani S; Tallapaka L; Dayananda D; Jen KL
J Lipid Res; 1992 Jan; 33(1):1-7. PubMed ID: 1552226
[TBL] [Abstract][Full Text] [Related]
4. [Preventive effect of simvastatin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis in cholesterol-fed rabbits].
Oogushi K
Fukuoka Igaku Zasshi; 1991 Feb; 82(2):36-47. PubMed ID: 2022360
[TBL] [Abstract][Full Text] [Related]
5. Effect of probucol on triglyceride turnover in streptozotocin-diabetic rats.
Yoshino G; Matsushita M; Maeda E; Nagata K; Morita M; Matsuba K; Tani T; Horinuki R; Kimura Y; Kazumi T
Atherosclerosis; 1991 May; 88(1):69-75. PubMed ID: 1878011
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
Alberts AW
Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
8. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
[TBL] [Abstract][Full Text] [Related]
10. Effect of mild diabetes and dietary fructose on very-low-density lipoprotein triglyceride turnover in rats.
Yoshino G; Matsushita M; Iwai M; Morita M; Matsuba K; Nagata K; Maeda E; Furukawa S; Hirano T; Kazumi T
Metabolism; 1992 Mar; 41(3):236-40. PubMed ID: 1542260
[TBL] [Abstract][Full Text] [Related]
11. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
Qin J; Zhang Z; Liu J; Sun L; Hu L; Cooper ME; Cao Z
Kidney Int; 2003 Aug; 64(2):565-71. PubMed ID: 12846751
[TBL] [Abstract][Full Text] [Related]
12. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase.
Schoonjans K; Peinado-Onsurbe J; Fruchart JC; Tailleux A; Fiévet C; Auwerx J
FEBS Lett; 1999 Jun; 452(3):160-4. PubMed ID: 10386582
[TBL] [Abstract][Full Text] [Related]
13. Effect of lovastatin on the secretion of very low density lipoprotein lipids and apolipoprotein B in the hypertriglyceridemic Zucker obese rat.
Kasim SE; Elovson J; Khilnani S; Almario RU; Jen KL
Atherosclerosis; 1993 Dec; 104(1-2):147-52. PubMed ID: 8141838
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in streptozotocin-diabetic rats is not reversed by dietary probucol or simvastatin supplementation.
Palmer AM; Gopaul N; Dhir S; Thomas CR; Poston L; Tribe RM
Diabetologia; 1998 Feb; 41(2):157-64. PubMed ID: 9498648
[TBL] [Abstract][Full Text] [Related]
15. Effects of MK-733 (simvastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on intestinal acylcoenzyme A:cholesterol acyltransferase activity in rabbits.
Ishida F; Sato A; Iizuka Y; Kitani K; Sawasaki Y; Kamei T
Biochim Biophys Acta; 1989 Jul; 1004(1):117-23. PubMed ID: 2742865
[TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
Krause BR; Newton RS
Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term insulin deficiency and insulin treatment on the composition of triglyceride-rich lipoproteins and triglyceride turnover in rats.
Yoshino G; Matsushita M; Maeda E; Naka Y; Nagata K; Morita M; Matsuba K; Kazumi T; Kasuga M
Atherosclerosis; 1992 Feb; 92(2-3):243-50. PubMed ID: 1632852
[TBL] [Abstract][Full Text] [Related]
18. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
19. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.
Chao Y; Chen JS; Hunt VM; Kuron GW; Karkas JD; Liou R; Alberts AW
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S11-4. PubMed ID: 2044637
[TBL] [Abstract][Full Text] [Related]
20. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
Hirano T; Komuro F; Furukawa S; Nagano S; Takahashi T
Metabolism; 1990 Jun; 39(6):605-9. PubMed ID: 2112675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
